PINDOLOL

PINDOLOL was reported 807 times

PINDOLOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMINO ACID LEVEL 1 0.3333
1 LIGNEOUS CONJUNCTIVITIS 2 0.2222
2 PHARYNGEAL CANDIDIASIS 1 0.0500
3 NASAL MUCOSAL HYPERTROPHY 1 0.0500
4 KAOLIN CEPHALIN CLOTTING TIME PROLONGED 1 0.0385
5 POST CARDIAC ARREST SYNDROME 1 0.0357
6 MUCINOUS ADENOCARCINOMA OF APPENDIX 1 0.0294
7 DIHYDROTESTOSTERONE DECREASED 1 0.0278
8 PERITONEAL LESION 2 0.0247
9 HAEMOGLOBIN 4 0.0201
10 NEUTROPHIL COUNT 4 0.0190
11 POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE II 1 0.0185
12 PLATELET AGGREGATION DECREASED 1 0.0132
13 LYMPHOCYTIC LYMPHOMA 1 0.0120
14 POST PROCEDURAL ERYTHEMA 1 0.0112
15 PERIPHERAL PULSE DECREASED 1 0.0103
16 NEONATAL PNEUMONIA 2 0.0085
17 LIMB RECONSTRUCTIVE SURGERY 1 0.0083
18 HYPERTROPHY OF TONGUE PAPILLAE 1 0.0083
19 VASCULAR ACCESS SITE COMPLICATION 2 0.0079
20 NEUTROPHIL COUNT ABNORMAL 21 0.0074
21 LABOUR INDUCTION 1 0.0074
22 CERVIX INFLAMMATION 1 0.0074
23 ELECTROCARDIOGRAM POOR R-WAVE PROGRESSION 1 0.0068
24 GLUCOSE URINE 1 0.0067
25 MESENTERITIS 1 0.0066
26 PREGNANCY INDUCED HYPERTENSION 1 0.0062
27 BREAST INJURY 1 0.0061
28 ANAEMIA OF PREGNANCY 1 0.0058
29 INTESTINAL SCARRING 1 0.0055
30 MELANODERMA 1 0.0052
31 BAND NEUTROPHIL COUNT INCREASED 1 0.0051
32 IMPLANT SITE MASS 1 0.0051
33 HERPES ZOSTER CUTANEOUS DISSEMINATED 1 0.0043
34 BUTTOCK PAIN 1 0.0042
35 PROSTATE EXAMINATION ABNORMAL 1 0.0041
36 IMMUNODEFICIENCY COMMON VARIABLE 2 0.0041
37 DIABETES MELLITUS INSULIN-DEPENDENT 2 0.0040
38 NEONATAL RESPIRATORY FAILURE 2 0.0040
39 WHITE BLOOD CELL COUNT ABNORMAL 23 0.0036
40 PENILE DISCHARGE 1 0.0036
41 AVULSION FRACTURE 1 0.0035
42 EYE INFECTION STAPHYLOCOCCAL 1 0.0035
43 HAEMOGLOBIN ABNORMAL 22 0.0034
44 SJOGREN'S SYNDROME 2 0.0034
45 POLYMYOSITIS 6 0.0034
46 MITRAL VALVE THICKENING 1 0.0034
47 URINARY SEDIMENT PRESENT 2 0.0031
48 NODAL OSTEOARTHRITIS 1 0.0031
49 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
50 POSTOPERATIVE ADHESION 2 0.0030
51 IODINE ALLERGY 1 0.0030
52 PANCREATIC NECROSIS 1 0.0029
53 TEETH BRITTLE 3 0.0029
54 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
55 ANOXIA 1 0.0028
56 BIPOLAR II DISORDER 1 0.0028
57 ORAL DISCHARGE 1 0.0027
58 CARDIAC ASSISTANCE DEVICE USER 1 0.0027
59 NASAL TURBINATE HYPERTROPHY 1 0.0027
60 MEDIASTINAL MASS 1 0.0026
61 INJECTION SITE BURNING 2 0.0026
62 HAEMATOMA MUSCLE 3 0.0025
63 COMPULSIVE SEXUAL BEHAVIOUR 2 0.0025
64 OESOPHAGITIS 27 0.0025
65 SEPSIS NEONATAL 2 0.0025
66 ANTEPARTUM HAEMORRHAGE 1 0.0024
67 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
68 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
69 DYSPHASIA 1 0.0021
70 MORPHOEA 1 0.0021
71 ARTIFICIAL CROWN PROCEDURE 1 0.0020
72 INTRAOCULAR LENS IMPLANT 1 0.0020
73 BREAST CANCER MALE 1 0.0020
74 LEFT VENTRICULAR DILATATION 1 0.0020
75 JOINT SPRAIN 2 0.0019
76 HYPERLIPASAEMIA 1 0.0019
77 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
78 DEMENTIA ALZHEIMER'S TYPE 3 0.0018
79 BONE FRAGMENTATION 1 0.0018
80 EJECTION FRACTION 1 0.0017
81 HEPATITIS C VIRUS TEST POSITIVE 1 0.0017
82 HYPOAESTHESIA EYE 1 0.0017
83 ADRENAL ADENOMA 1 0.0017
84 INDUCED LABOUR 1 0.0017
85 ALLERGY TO METALS 1 0.0016
86 PITTING OEDEMA 1 0.0016
87 ARTERITIS 1 0.0016
88 NEUROPATHIC ARTHROPATHY 1 0.0015
89 CHONDROCALCINOSIS 1 0.0015
90 ABSCESS NECK 1 0.0015
91 PLEURAL THICKENING 1 0.0015
92 DELUSIONAL DISORDER, UNSPECIFIED TYPE 1 0.0013
93 PERFORATED ULCER 1 0.0013
94 OBSTRUCTIVE PANCREATITIS 1 0.0013
95 ELECTROCARDIOGRAM PR PROLONGATION 1 0.0013
96 CAUDA EQUINA SYNDROME 1 0.0013
97 GRIMACING 1 0.0013
98 PRE-EXISTING CONDITION IMPROVED 8 0.0013
99 NEONATAL DISORDER 2 0.0013
100 PLACENTAL INSUFFICIENCY 1 0.0012
101 RESPIRATORY DISORDER NEONATAL 2 0.0012
102 KETONURIA 1 0.0012
103 NEONATAL HYPOXIA 1 0.0012
104 HYPOPYON 1 0.0012
105 MITRAL VALVE PROLAPSE 2 0.0012
106 ENZYME LEVEL INCREASED 1 0.0012
107 INTENTIONAL DEVICE USE ISSUE 1 0.0012
108 ALLERGIC SINUSITIS 1 0.0012
109 GINGIVAL ERYTHEMA 1 0.0012
110 GENITAL BURNING SENSATION 1 0.0012
111 DIVERTICULUM 8 0.0011
112 WHITE BLOOD CELL DISORDER 3 0.0011
113 PLEUROTHOTONUS 1 0.0011
114 ANAEMIA OF CHRONIC DISEASE 1 0.0011
115 PRIMARY SEQUESTRUM 1 0.0011
116 ESSENTIAL HYPERTENSION 2 0.0011
117 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
118 JAUNDICE NEONATAL 2 0.0011
119 APPLICATION SITE BRUISE 1 0.0010
120 HAEMOPHILUS INFECTION 1 0.0010
121 DUST ALLERGY 1 0.0010
122 OROPHARYNGEAL SWELLING 1 0.0010
123 ANTISOCIAL BEHAVIOUR 1 0.0010
124 REBOUND ACID HYPERSECRETION 3 0.0010
125 BREAST NEOPLASM 1 0.0010
126 IMPAIRED SELF-CARE 2 0.0010
127 ABSCESS JAW 1 0.0010
128 POST LUMBAR PUNCTURE SYNDROME 1 0.0010
129 CEREBRAL ARTERY OCCLUSION 1 0.0009
130 CLAUSTROPHOBIA 1 0.0009
131 POST PROCEDURAL SWELLING 1 0.0009
132 NAIL GROWTH ABNORMAL 1 0.0009
133 AORTIC DILATATION 1 0.0009
134 BACTERIAL TEST POSITIVE 2 0.0009
135 BENIGN NEOPLASM 1 0.0009
136 ONYCHOCLASIS 6 0.0009
137 ADMINISTRATION SITE PAIN 1 0.0009
138 POLYDACTYLY 1 0.0009
139 HANGOVER 3 0.0009
140 LABILE BLOOD PRESSURE 1 0.0008
141 BLEEDING TIME PROLONGED 1 0.0008
142 BLOOD UREA DECREASED 1 0.0008
143 FRACTURED SACRUM 1 0.0008
144 APPLICATION SITE SCAR 1 0.0008
145 NEPHRITIS INTERSTITIAL 1 0.0008
146 CAROTID ARTERY DISEASE 1 0.0008
147 LEFT ATRIAL DILATATION 1 0.0008
148 INFUSION SITE IRRITATION 1 0.0008
149 NON-HODGKIN'S LYMPHOMA 1 0.0008
150 DEVICE MISUSE 1 0.0008
151 ANGIONEUROTIC OEDEMA 2 0.0007
152 GAMBLING DISORDER 2 0.0007
153 CLUSTER HEADACHE 1 0.0007
154 HEAD TITUBATION 1 0.0007
155 PERITONEAL HAEMORRHAGE 1 0.0007
156 ANGIOPATHY 4 0.0007
157 CATAPLEXY 1 0.0007
158 NAIL INFECTION 1 0.0007
159 HYPERTONIC BLADDER 2 0.0007
160 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
161 DYSPNOEA AT REST 2 0.0007
162 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
163 DIABETES MELLITUS NON-INSULIN-DEPENDENT 1 0.0007
164 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
165 HAEMORRHAGIC ANAEMIA 3 0.0007
166 GENERALISED ANXIETY DISORDER 1 0.0007
167 PRECANCEROUS SKIN LESION 1 0.0007
168 EXCESSIVE EYE BLINKING 1 0.0007
169 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
170 RHABDOMYOLYSIS 28 0.0007
171 URINE ANALYSIS ABNORMAL 2 0.0007
172 MENTAL FATIGUE 1 0.0007
173 CHROMATURIA 15 0.0007
174 GINGIVAL HYPERTROPHY 1 0.0007
175 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
176 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
177 FUNGAEMIA 1 0.0006
178 INTERMITTENT CLAUDICATION 1 0.0006
179 COLON CANCER METASTATIC 1 0.0006
180 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
181 HYPOGLYCAEMIA NEONATAL 1 0.0006
182 COSTOCHONDRITIS 1 0.0006
183 DENTAL IMPLANTATION 1 0.0006
184 SOMNAMBULISM 4 0.0006
185 INTESTINAL POLYP 1 0.0006
186 COLONIC POLYP 1 0.0006
187 POST PROCEDURAL HAEMATOMA 1 0.0006
188 CLOSTRIDIAL INFECTION 2 0.0006
189 EROSIVE OESOPHAGITIS 1 0.0006
190 FEMALE GENITAL TRACT FISTULA 1 0.0006
191 BRONCHOPNEUMONIA 2 0.0006
192 BLOOD CHLORIDE INCREASED 1 0.0006
193 BREAST DISCHARGE 1 0.0006
194 EMBOLIC STROKE 2 0.0006
195 NEONATAL RESPIRATORY DISTRESS SYNDROME 2 0.0006
196 MUSCLE CRAMP 1 0.0006
197 OPHTHALMIC HERPES ZOSTER 1 0.0006
198 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
199 OESOPHAGEAL SPASM 1 0.0005
200 LOBAR PNEUMONIA 1 0.0005
201 DENTAL CARE 1 0.0005
202 INFECTED SKIN ULCER 1 0.0005
203 SNORING 2 0.0005
204 PANCREATIC CYST 1 0.0005
205 GINGIVAL DISORDER 2 0.0005
206 PANIC DISORDER 2 0.0005
207 GALLBLADDER INJURY 1 0.0005
208 CARDIOPULMONARY FAILURE 2 0.0005
209 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
210 POLYDIPSIA 2 0.0005
211 EXPOSURE VIA BREAST MILK 2 0.0005
212 EJACULATION FAILURE 1 0.0005
213 ENURESIS 2 0.0005
214 SPINAL FUSION SURGERY 2 0.0005
215 SPINAL STENOSIS 2 0.0005
216 SPINAL COMPRESSION FRACTURE 4 0.0005
217 LIVEDO RETICULARIS 1 0.0005
218 PURULENT DISCHARGE 2 0.0005
219 JAW FRACTURE 1 0.0005
220 EXPOSED BONE IN JAW 1 0.0005
221 CERVICAL DYSPLASIA 1 0.0005
222 LIMB MASS 1 0.0005
223 NOSOCOMIAL INFECTION 1 0.0005
224 INFECTIOUS MONONUCLEOSIS 1 0.0004
225 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
226 FEAR OF DEATH 1 0.0004
227 LARGE INTESTINE POLYP 3 0.0004
228 RENAL FUNCTION TEST ABNORMAL 2 0.0004
229 NECK SURGERY 1 0.0004
230 PATELLA FRACTURE 1 0.0004
231 CARPAL TUNNEL SYNDROME 6 0.0004
232 SUSPECTED SUICIDE 2 0.0004
233 SKIN ABRASION 2 0.0004
234 PRE-ECLAMPSIA 2 0.0004
235 MEDICATION RESIDUE PRESENT 2 0.0004
236 ORAL INTAKE REDUCED 1 0.0004
237 BREATH ODOUR 1 0.0004
238 MUCOUS STOOLS 2 0.0004
239 HYPERPARATHYROIDISM SECONDARY 1 0.0004
240 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
241 CANCER PAIN 1 0.0004
242 LIPOMA 1 0.0004
243 PARTIAL SEIZURES 2 0.0004
244 LOW BIRTH WEIGHT BABY 3 0.0004
245 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
246 ALCOHOL ABUSE 1 0.0004
247 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
248 BRUXISM 2 0.0004
249 BLOOD SODIUM INCREASED 1 0.0004
250 BRADYPNOEA 1 0.0004
251 BEHAVIOUR DISORDER 2 0.0004
252 EAR CONGESTION 1 0.0004
253 MIGRAINE WITH AURA 1 0.0004
254 DRUG TOXICITY 5 0.0004
255 BLOOD PHOSPHORUS INCREASED 1 0.0004
256 PREMATURE LABOUR 2 0.0004
257 OXYGEN SATURATION ABNORMAL 1 0.0004
258 OESOPHAGEAL STENOSIS 1 0.0004
259 DUODENAL ULCER HAEMORRHAGE 1 0.0003
260 VENTRICULAR SEPTAL DEFECT 2 0.0003
261 LUMBAR SPINAL STENOSIS 1 0.0003
262 HYPERLIPIDAEMIA 4 0.0003
263 ATYPICAL PNEUMONIA 1 0.0003
264 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
265 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
266 PROSTATITIS 1 0.0003
267 DYSCHEZIA 1 0.0003
268 MASTICATION DISORDER 1 0.0003
269 CHEST X-RAY ABNORMAL 1 0.0003
270 SMALL INTESTINAL OBSTRUCTION 4 0.0003
271 INFUSION SITE EXTRAVASATION 2 0.0003
272 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
273 INFUSION SITE PRURITUS 1 0.0003
274 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
275 HYPERCHOLESTEROLAEMIA 3 0.0003
276 LOOSE TOOTH 1 0.0003
277 VITAMIN D DEFICIENCY 3 0.0003
278 HYPOVENTILATION 1 0.0003
279 WALKING AID USER 2 0.0003
280 OTITIS MEDIA 1 0.0003
281 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
282 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
283 PEPTIC ULCER 1 0.0003
284 ANXIETY DISORDER 1 0.0003
285 MALIGNANT MELANOMA 4 0.0003
286 POST-TRAUMATIC STRESS DISORDER 2 0.0003
287 PLANTAR FASCIITIS 1 0.0003
288 SLUGGISHNESS 3 0.0003
289 ABNORMAL LOSS OF WEIGHT 2 0.0003
290 DROOLING 2 0.0003
291 URINARY TRACT INFECTION 49 0.0003
292 SEPSIS 32 0.0003
293 EAR PRURITUS 1 0.0003
294 HAEMORRHAGIC DIATHESIS 1 0.0003
295 HEREDITARY ANGIOEDEMA 3 0.0003
296 FRUSTRATION 1 0.0003
297 MONOCYTE COUNT INCREASED 1 0.0003
298 MOUTH HAEMORRHAGE 2 0.0003
299 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
300 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
301 FREEZING PHENOMENON 1 0.0003
302 HYPERACUSIS 1 0.0003
303 LEUKOENCEPHALOPATHY 1 0.0003
304 AUTOIMMUNE THYROIDITIS 1 0.0003
305 COMMUNICATION DISORDER 1 0.0003
306 CLAVICLE FRACTURE 1 0.0003
307 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
308 CONCUSSION 2 0.0003
309 CERVIX CARCINOMA 1 0.0003
310 ORAL INFECTION 1 0.0003
311 PROSTATOMEGALY 1 0.0003
312 DRUG SCREEN POSITIVE 2 0.0003
313 DISABILITY 5 0.0003
314 DRUG INTERACTION 40 0.0003
315 PATENT DUCTUS ARTERIOSUS 1 0.0003
316 CEREBRAL ATROPHY 1 0.0003
317 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
318 CANDIDIASIS 1 0.0002
319 BLEPHARITIS 1 0.0002
320 TARDIVE DYSKINESIA 7 0.0002
321 MYASTHENIA GRAVIS 2 0.0002
322 FIBROMYALGIA 6 0.0002
323 PERIPHERAL VENOUS DISEASE 1 0.0002
324 HYPERURICAEMIA 1 0.0002
325 ANAPHYLACTOID REACTION 1 0.0002
326 LEG AMPUTATION 1 0.0002
327 PULMONARY HYPERTENSION 5 0.0002
328 BLOOD UREA INCREASED 4 0.0002
329 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
330 INTESTINAL STENOSIS 1 0.0002
331 HYPERPYREXIA 1 0.0002
332 BUNDLE BRANCH BLOCK LEFT 1 0.0002
333 RENAL INJURY 7 0.0002
334 INTERVERTEBRAL DISC DISORDER 1 0.0002
335 ABNORMAL SENSATION IN EYE 1 0.0002
336 METASTATIC NEOPLASM 1 0.0002
337 RASH GENERALISED 6 0.0002
338 HAEMATOMA 6 0.0002
339 CORONARY ARTERY DISEASE 7 0.0002
340 ORTHOSTATIC HYPOTENSION 4 0.0002
341 DIVERTICULUM INTESTINAL 1 0.0002
342 ONYCHOMYCOSIS 1 0.0002
343 SPINAL OSTEOARTHRITIS 2 0.0002
344 ADVERSE REACTION 3 0.0002
345 BLOOD CREATINE INCREASED 1 0.0002
346 STEVENS-JOHNSON SYNDROME 5 0.0002
347 HAIR TEXTURE ABNORMAL 3 0.0002
348 FEAR 6 0.0002
349 PAPILLOEDEMA 1 0.0002
350 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
351 IMPAIRED GASTRIC EMPTYING 3 0.0002
352 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
353 NERVE COMPRESSION 2 0.0002
354 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
355 NEPHROGENIC ANAEMIA 1 0.0002
356 PRODUCT DISTRIBUTION ISSUE 2 0.0002
357 PERSONALITY CHANGE 2 0.0002
358 AGRANULOCYTOSIS 4 0.0002
359 ERYTHEMA MULTIFORME 2 0.0002
360 APPENDICITIS 2 0.0002
361 ARTERIOSCLEROSIS 2 0.0002
362 MUSCULAR WEAKNESS 24 0.0002
363 COLITIS MICROSCOPIC 1 0.0002
364 BLOOD URINE PRESENT 4 0.0002
365 SLEEP APNOEA SYNDROME 4 0.0002
366 NON-SMALL CELL LUNG CANCER 1 0.0002
367 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
368 KIDNEY TRANSPLANT REJECTION 1 0.0002
369 HUMERUS FRACTURE 1 0.0002
370 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
371 DYSSTASIA 6 0.0002
372 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
373 SKIN HAEMORRHAGE 3 0.0002
374 HAEMATOCRIT DECREASED 4 0.0002
375 ABDOMINAL TENDERNESS 1 0.0002
376 PROTEIN URINE PRESENT 1 0.0002
377 HEPATIC ENZYME ABNORMAL 1 0.0002
378 SALIVARY HYPERSECRETION 2 0.0002
379 DERMATITIS EXFOLIATIVE 1 0.0002
380 BLOOD CREATININE INCREASED 13 0.0002
381 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
382 PATHOLOGICAL FRACTURE 1 0.0002
383 DYSLIPIDAEMIA 1 0.0002
384 TOOTH ABSCESS 2 0.0002
385 INSURANCE ISSUE 3 0.0002
386 AMMONIA INCREASED 1 0.0002
387 PHARYNGEAL OEDEMA 3 0.0002
388 INCREASED UPPER AIRWAY SECRETION 1 0.0002
389 CEREBRAL ISCHAEMIA 1 0.0002
390 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
391 FAILURE TO THRIVE 1 0.0002
392 TENDERNESS 2 0.0002
393 BRAIN FOG 3 0.0002
394 HALLUCINATION, VISUAL 4 0.0002
395 PNEUMOTHORAX 3 0.0002
396 OSTEOARTHRITIS 8 0.0002
397 BRADYCARDIA 10 0.0002
398 GINGIVITIS 1 0.0002
399 SKIN LACERATION 2 0.0002
400 PULMONARY THROMBOSIS 2 0.0002
401 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
402 JAW DISORDER 1 0.0002
403 DENTAL CARIES 2 0.0002
404 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
405 FOOT DEFORMITY 2 0.0002
406 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
407 BLOOD CALCIUM DECREASED 2 0.0002
408 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
409 CHOLECYSTITIS ACUTE 1 0.0002
410 IMPAIRED DRIVING ABILITY 2 0.0002
411 EXERCISE TOLERANCE DECREASED 1 0.0002
412 HERPES VIRUS INFECTION 1 0.0002
413 CAESAREAN SECTION 2 0.0002
414 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
415 HEART RATE DECREASED 6 0.0002
416 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
417 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
418 BLOOD IRON DECREASED 2 0.0002
419 CATARACT OPERATION 1 0.0002
420 PLEURISY 1 0.0002
421 BLOOD PRESSURE FLUCTUATION 4 0.0002
422 SYNOVITIS 3 0.0002
423 BLOOD POTASSIUM DECREASED 5 0.0002
424 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
425 PREMATURE BABY 5 0.0002
426 HEPATITIS CHOLESTATIC 1 0.0002
427 INJECTION SITE VESICLES 1 0.0002
428 BURSITIS 2 0.0002
429 INGUINAL HERNIA 1 0.0002
430 SPINAL OPERATION 2 0.0002
431 CYST 2 0.0002
432 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
433 APPLICATION SITE IRRITATION 2 0.0002
434 TOOTH EXTRACTION 2 0.0002
435 INFUSION SITE SWELLING 1 0.0002
436 PROTEINURIA 3 0.0002
437 FEELING JITTERY 3 0.0002
438 FOREIGN BODY SENSATION IN EYES 1 0.0002
439 PROCTALGIA 1 0.0002
440 HIP FRACTURE 5 0.0002
441 INFUSION SITE PAIN 2 0.0002
442 ANOREXIA 2 0.0002
443 ERUCTATION 3 0.0002
444 CARDIAC FLUTTER 1 0.0002
445 HIATUS HERNIA 2 0.0002
446 HYPERPROLACTINAEMIA 1 0.0002
447 APPLICATION SITE VESICLES 1 0.0002
448 CHOKING 3 0.0002
449 POLYP 1 0.0002
450 ANHEDONIA 4 0.0002
451 PRODUCT FORMULATION ISSUE 1 0.0002
452 CATARACT 9 0.0002
453 APPETITE DISORDER 1 0.0002
454 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
455 POSTOPERATIVE WOUND INFECTION 1 0.0001
456 HAEMOGLOBIN DECREASED 15 0.0001
457 ECCHYMOSIS 1 0.0001
458 CORONARY ARTERY OCCLUSION 2 0.0001
459 JOINT EFFUSION 1 0.0001
460 ENCEPHALITIS 1 0.0001
461 HAIR GROWTH ABNORMAL 1 0.0001
462 LARGE INTESTINE PERFORATION 1 0.0001
463 APHONIA 2 0.0001
464 MASS 2 0.0001
465 DEFAECATION URGENCY 1 0.0001
466 APPLICATION SITE REACTION 1 0.0001
467 SEASONAL ALLERGY 2 0.0001
468 MYALGIA 24 0.0001
469 JOINT INJURY 3 0.0001
470 FEAR OF INJECTION 1 0.0001
471 METASTASIS 1 0.0001
472 NEUTROPENIC SEPSIS 1 0.0001
473 IRRITABLE BOWEL SYNDROME 3 0.0001
474 PARALYSIS 2 0.0001
475 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
476 HYPERSOMNIA 4 0.0001
477 PANIC REACTION 1 0.0001
478 FLUID RETENTION 7 0.0001
479 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
480 HYPERGLYCAEMIA 5 0.0001
481 PANIC ATTACK 5 0.0001
482 BLINDNESS TRANSIENT 1 0.0001
483 URINARY INCONTINENCE 4 0.0001
484 FEELING DRUNK 1 0.0001
485 APHASIA 4 0.0001
486 COMPLETED SUICIDE 11 0.0001
487 BLOOD COUNT ABNORMAL 2 0.0001
488 OSTEOPENIA 2 0.0001
489 HYPERTHERMIA 1 0.0001
490 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
491 LIPASE INCREASED 1 0.0001
492 MUSCLE TWITCHING 3 0.0001
493 CONGENITAL ANOMALY 1 0.0001
494 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
495 SWOLLEN TONGUE 4 0.0001
496 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
497 ARRHYTHMIA 6 0.0001
498 RESPIRATORY TRACT CONGESTION 2 0.0001
499 ATRIAL FLUTTER 1 0.0001
500 BLOOD DISORDER 1 0.0001
501 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
502 MIOSIS 1 0.0001
503 MENTAL IMPAIRMENT 3 0.0001
504 ATRIAL FIBRILLATION 12 0.0001
505 BLOOD POTASSIUM INCREASED 2 0.0001
506 AMNESIA 8 0.0001
507 CHOLELITHIASIS 4 0.0001
508 METASTASES TO BONE 2 0.0001
509 HYPERAESTHESIA 1 0.0001
510 ESCHERICHIA INFECTION 1 0.0001
511 HAIR DISORDER 1 0.0001
512 BLOOD PRESSURE DECREASED 8 0.0001
513 SYNCOPE 12 0.0001
514 SKIN DISORDER 4 0.0001
515 DRUG USE DISORDER 1 0.0001
516 INFUSION SITE ERYTHEMA 1 0.0001
517 CHRONIC KIDNEY DISEASE 9 0.0001
518 HAEMATEMESIS 3 0.0001
519 CIRCULATORY COLLAPSE 2 0.0001
520 SCAR 2 0.0001
521 CARDIAC OPERATION 1 0.0001
522 PARANOIA 2 0.0001
523 MUSCLE STRAIN 1 0.0001
524 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
525 DELIRIUM 4 0.0001
526 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
527 NAIL DISORDER 1 0.0001
528 BLOOD CALCIUM INCREASED 1 0.0001
529 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
530 LYMPHOCYTE COUNT DECREASED 2 0.0001
531 BREAST CANCER FEMALE 3 0.0001
532 GALLBLADDER DISORDER 2 0.0001
533 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
534 HAEMOLYTIC ANAEMIA 1 0.0001
535 MYOSITIS 1 0.0001
536 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
537 THROAT IRRITATION 5 0.0001
538 BLOOD PRESSURE INCREASED 17 0.0001
539 GASTROENTERITIS VIRAL 2 0.0001
540 BONE DISORDER 2 0.0001
541 EXOSTOSIS 1 0.0001
542 HAEMATOCHEZIA 6 0.0001
543 INCREASED TENDENCY TO BRUISE 1 0.0001
544 HYPERHIDROSIS 14 0.0001
545 IRON DEFICIENCY ANAEMIA 1 0.0001
546 GRAND MAL CONVULSION 1 0.0001
547 BRONCHITIS 8 0.0001
548 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
549 MENTAL STATUS CHANGES 3 0.0001
550 CONJUNCTIVITIS 2 0.0001
551 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
552 EYE SWELLING 4 0.0001
553 THINKING ABNORMAL 2 0.0001
554 HEPATIC ENCEPHALOPATHY 1 0.0001
555 NEPHROPATHY 1 0.0001
556 DEFORMITY 1 0.0001
557 HYPONATRAEMIA 6 0.0001
558 LACERATION 1 0.0001
559 HALLUCINATION 8 0.0001
560 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
561 FLATULENCE 6 0.0001
562 UNEVALUABLE EVENT 8 0.0001
563 GASTRIC ULCER 2 0.0001
564 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
565 DIABETES MELLITUS 8 0.0001
566 LETHARGY 6 0.0001
567 PRODUCT SUBSTITUTION ISSUE 6 0.0001
568 AFFECT LABILITY 1 0.0001
569 MUSCLE SPASMS 19 0.0001
570 HERNIA 2 0.0001
571 PRESCRIBED OVERDOSE 2 0.0001
572 LIVER FUNCTION TEST ABNORMAL 3 0.0001
573 PARKINSONISM 1 0.0001
574 HAEMORRHOIDS 2 0.0001
575 COELIAC DISEASE 1 0.0001
576 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
577 HEPATOMEGALY 1 0.0001
578 DYSPEPSIA 10 0.0001
579 BODY TEMPERATURE DECREASED 1 0.0001
580 TACHYCARDIA 9 0.0001
581 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
582 SINUS DISORDER 2 0.0001
583 BLADDER DISORDER 1 0.0001
584 INABILITY TO AFFORD MEDICATION 1 0.0001
585 BLOOD PRESSURE ABNORMAL 2 0.0001
586 HYPOTONIA 1 0.0001
587 CARDIAC FAILURE CONGESTIVE 8 0.0001
588 DRY THROAT 1 0.0001
589 DRUG LEVEL DECREASED 1 0.0001
590 NEUTROPHIL COUNT INCREASED 1 0.0001
591 INITIAL INSOMNIA 1 0.0001
592 OSTEOPOROSIS 4 0.0001
593 DEPRESSION 22 0.0001
594 FALL 32 0.0001
595 BONE DENSITY DECREASED 3 0.0001
596 PRODUCT ODOUR ABNORMAL 1 0.0001
597 KNEE ARTHROPLASTY 2 0.0001
598 INCONTINENCE 1 0.0001
599 JOINT DISLOCATION 1 0.0001
600 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
601 MIGRAINE 9 0.0001
602 CYSTITIS 3 0.0001
603 HYPOTHYROIDISM 3 0.0001
604 EATING DISORDER 2 0.0001
605 BREAST PAIN 1 0.0001
606 BODY HEIGHT DECREASED 1 0.0001
607 DRUG EFFECT DECREASED 5 0.0001
608 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
609 RASH PRURITIC 5 0.0001
610 FAECES DISCOLOURED 2 0.0001
611 BIPOLAR DISORDER 1 0.0001
612 BACK INJURY 1 0.0001
613 GASTROINTESTINAL PAIN 1 0.0001
614 VISUAL ACUITY REDUCED 3 0.0001
615 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
616 VIRAL INFECTION 3 0.0001
617 HYPOTENSION 18 0.0001
618 HYPERTENSION 19 0.0001
619 NECK PAIN 5 0.0001
620 MALNUTRITION 1 0.0001
621 RASH PAPULAR 2 0.0001
622 PANCREATITIS ACUTE 2 0.0001
623 OXYGEN SATURATION DECREASED 5 0.0001
624 FLUSHING 9 0.0001
625 APPLICATION SITE PRURITUS 2 0.0001
626 CHEST DISCOMFORT 9 0.0001
627 HAEMATURIA 3 0.0001
628 GASTRIC DISORDER 3 0.0001
629 TINNITUS 4 0.0001
630 HYPOAESTHESIA 13 0.0001
631 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
632 MADAROSIS 1 0.0001
633 ELECTROLYTE IMBALANCE 1 0.0001
634 EYELID OEDEMA 1 0.0001
635 POST PROCEDURAL HAEMORRHAGE 1 0.0001
636 BLOOD CHOLESTEROL INCREASED 4 0.0001
637 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
638 HYPERKALAEMIA 3 0.0001
639 TREMOR 14 0.0001
640 DYSPHAGIA 8 0.0001
641 CHOLECYSTITIS 1 0.0001
642 MYOCLONUS 1 0.0001
643 ACCIDENT 1 0.0001
644 MUSCLE RIGIDITY 1 0.0001
645 POLYNEUROPATHY 1 0.0001
646 RENAL FAILURE 11 0.0001
647 HYPOGLYCAEMIA 4 0.0001
648 NOCTURIA 1 0.0001
649 DIZZINESS 41 0.0001
650 OEDEMA PERIPHERAL 10 0.0001
651 NO THERAPEUTIC RESPONSE 1 0.0001
652 RESTLESSNESS 3 0.0001
653 FEELING HOT 5 0.0001
654 INJECTION SITE URTICARIA 2 0.0001
655 DYSURIA 3 0.0001
656 CARDIOMEGALY 1 0.0001
657 HYPERCALCAEMIA 1 0.0001
658 CONFUSIONAL STATE 13 0.0001
659 HAIR COLOUR CHANGES 1 0.0001
660 EPISTAXIS 6 0.0001
661 MUSCULOSKELETAL STIFFNESS 7 0.0001
662 HOT FLUSH 6 0.0001
663 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
664 ACUTE KIDNEY INJURY 12 0.0001
665 SINUSITIS 8 0.0001
666 LOSS OF CONSCIOUSNESS 10 0.0001
667 MYDRIASIS 1 0.0001
668 SEIZURE 9 0.0001
669 ERECTILE DYSFUNCTION 2 0.0001
670 ANAPHYLACTIC SHOCK 2 0.0001
671 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
672 UNRESPONSIVE TO STIMULI 2 0.0001
673 INJECTION SITE INDURATION 1 0.0001
674 SWELLING FACE 5 0.0001
675 SEDATION 2 0.0001
676 APPLICATION SITE ERYTHEMA 2 0.0001
677 ARTHRITIS 6 0.0001
678 BEDRIDDEN 1 0.0001
679 GASTRITIS 2 0.0001
680 WEIGHT INCREASED 17 0.0001
681 ANKYLOSING SPONDYLITIS 1 0.0001
682 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
683 EYE HAEMORRHAGE 1 0.0001
684 ABORTION SPONTANEOUS 3 0.0001
685 JOINT RANGE OF MOTION DECREASED 1 0.0001
686 DYSPNOEA 42 0.0001
687 BLOOD BILIRUBIN INCREASED 2 0.0001
688 PRODUCT TASTE ABNORMAL 1 0.0001
689 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
690 OEDEMA 4 0.0001
691 SKIN LESION 2 0.0001
692 INFLUENZA LIKE ILLNESS 6 0.0001
693 APPLICATION SITE RASH 1 0.0001
694 RESPIRATORY ARREST 2 0.0001
695 DIVERTICULITIS 2 0.0001
696 PROCEDURAL PAIN 2 0.0001
697 ARTHROPATHY 4 0.0001
698 FEELING COLD 2 0.0001
699 DEMENTIA 2 0.0001
700 BURNING SENSATION 5 0.0001
701 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
702 DEVICE OCCLUSION 1 0.0001
703 RENAL FAILURE ACUTE 3 0.0001
704 HEART RATE INCREASED 7 0.0001
705 DIALYSIS 1 0.0001
706 INTENTIONAL DOSE OMISSION 2 0.0001
707 RED BLOOD CELL COUNT DECREASED 2 0.0001
708 PARAESTHESIA 11 0.0001
709 CARDIOGENIC SHOCK 1 0.0001
710 IMPAIRED QUALITY OF LIFE 1 0.0001
711 VAGINAL HAEMORRHAGE 3 0.0001
712 ANOSMIA 1 0.0001
713 SEPTIC SHOCK 3 0.0001
714 HYPOKINESIA 1 0.0001
715 FLUID OVERLOAD 1 0.0001
716 APATHY 1 0.0001
717 GASTROENTERITIS 1 0.0001
718 UNDERDOSE 5 0.0001
719 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
720 SURGERY 4 0.0001
721 NASAL CONGESTION 4 0.0001
722 ILLNESS 7 0.0001
723 PSYCHOTIC DISORDER 2 0.0001
724 DYSGEUSIA 5 0.0001
725 PULMONARY OEDEMA 3 0.0001
726 BONE LOSS 1 0.0001
727 ALOPECIA 13 0.0001
728 ECONOMIC PROBLEM 1 0.0001
729 THERAPEUTIC RESPONSE DECREASED 4 0.0001
730 DEVICE FAILURE 1 0.0001
731 SUICIDAL IDEATION 6 0.0001
732 DRUG DISPENSING ERROR 1 0.0001
733 DRUG ADMINISTRATION ERROR 2 0.0001
734 PNEUMONIA 21 0.0001
735 GYNAECOMASTIA 2 0.0001
736 LIMB DISCOMFORT 2 0.0001
737 FEMUR FRACTURE 2 0.0001
738 RENAL DISORDER 3 0.0001
739 LUNG INFECTION 1 0.0001
740 SWELLING 6 0.0001
741 BASAL CELL CARCINOMA 1 0.0001
742 NERVOUS SYSTEM DISORDER 2 0.0001
743 INSOMNIA 17 0.0001
744 CYANOSIS 1 0.0001
745 PRODUCT USE COMPLAINT 1 0.0001
746 ERYTHEMA 13 0.0001
747 HEAD INJURY 2 0.0001
748 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
749 MYOCARDIAL INFARCTION 11 0.0001
750 HALLUCINATION, AUDITORY 1 0.0001
751 OBESITY 1 0.0001
752 BLOOD GLUCOSE DECREASED 3 0.0001
753 CARDIAC FAILURE 5 0.0001
754 DEEP VEIN THROMBOSIS 4 0.0001
755 BACK DISORDER 1 0.0001
756 PAIN IN EXTREMITY 18 0.0001
757 IMPAIRED HEALING 2 0.0001
758 WEIGHT DECREASED 17 0.0001
759 MULTIPLE FRACTURES 1 0.0001
760 MANIA 1 0.0001
761 STAPHYLOCOCCAL INFECTION 2 0.0001
762 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
763 DEHYDRATION 8 0.0001
764 AGGRESSION 3 0.0001
765 PALPITATIONS 7 0.0001
766 CHILLS 7 0.0001
767 EYE PRURITUS 2 0.0001
768 CHEST PAIN 11 0.0001
769 HEMIPARESIS 1 0.0001
770 CEREBROVASCULAR ACCIDENT 10 0.0001
771 METRORRHAGIA 1 0.0001
772 HOSPITALISATION 9 0.0001
773 ABDOMINAL PAIN UPPER 12 0.0001
774 MUSCULOSKELETAL DISCOMFORT 1 0.0001
775 BALANCE DISORDER 5 0.0001
776 MULTI-ORGAN FAILURE 1 0.0001
777 ANAEMIA 11 0.0001
778 LOCAL SWELLING 1 0.0001
779 MUSCULOSKELETAL PAIN 3 0.0001
780 SPEECH DISORDER 3 0.0001
781 EOSINOPHILIA 1 0.0001
782 INJURY 4 0.0001
783 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
784 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
785 PRODUCT ADHESION ISSUE 2 0.0001
786 DECREASED APPETITE 13 0.0001
787 BACK PAIN 13 0.0001
788 GOUT 1 0.0001
789 NAUSEA 44 0.0001
790 LEUKOCYTOSIS 1 0.0001
791 FATIGUE 43 0.0001
792 OSTEOMYELITIS 1 0.0001
793 CRYING 2 0.0001
794 C-REACTIVE PROTEIN INCREASED 2 0.0001
795 RESPIRATORY FAILURE 4 0.0001
796 END STAGE RENAL DISEASE 1 0.0001
797 AGITATION 4 0.0001
798 DRUG DOSE OMISSION 9 0.0001
799 NASOPHARYNGITIS 10 0.0001
800 INFLUENZA 6 0.0001
801 HEPATIC STEATOSIS 1 0.0001
802 TOXICITY TO VARIOUS AGENTS 9 0.0001
803 DYSPNOEA EXERTIONAL 2 0.0001
804 BLOOD SODIUM DECREASED 1 0.0001
805 FOOT FRACTURE 1 0.0001
806 ANXIETY 15 0.0001
807 NEUROPATHY PERIPHERAL 5 0.0001
808 CONVULSION 3 0.0001
809 HERPES ZOSTER 3 0.0001
810 POST PROCEDURAL COMPLICATION 1 0.0001
811 DRUG PRESCRIBING ERROR 1 0.0001
812 ACUTE RESPIRATORY FAILURE 1 0.0001
813 CONTUSION 5 0.0001
814 GLAUCOMA 1 0.0001
815 DYSTONIA 1 0.0001
816 NEUTROPENIA 7 0.0001
817 DYSPHONIA 3 0.0001
818 ORAL HERPES 1 0.0001
819 MENORRHAGIA 1 0.0001
820 DISORIENTATION 2 0.0001
821 SOMNOLENCE 10 0.0000
822 FEEDING DISORDER 1 0.0000
823 DYSKINESIA 2 0.0000
824 INJURY ASSOCIATED WITH DEVICE 1 0.0000
825 PRODUCT PREPARATION ERROR 1 0.0000
826 LUNG NEOPLASM MALIGNANT 2 0.0000
827 CARDIAC ARREST 4 0.0000
828 DIARRHOEA 31 0.0000
829 POLLAKIURIA 2 0.0000
830 INTENTIONAL DRUG MISUSE 1 0.0000
831 LIVER FUNCTION TEST INCREASED 1 0.0000
832 POOR QUALITY SLEEP 1 0.0000
833 RHINORRHOEA 3 0.0000
834 COUGH 13 0.0000
835 ARTHRALGIA 19 0.0000
836 MALAISE 20 0.0000
837 PERIPHERAL SWELLING 7 0.0000
838 ASTHENIA 17 0.0000
839 ADVERSE DRUG REACTION 4 0.0000
840 RHEUMATOID ARTHRITIS 5 0.0000
841 VISION BLURRED 6 0.0000
842 OROPHARYNGEAL PAIN 4 0.0000
843 ABDOMINAL PAIN 10 0.0000
844 COGNITIVE DISORDER 2 0.0000
845 BLOOD GLUCOSE INCREASED 8 0.0000
846 PAIN 26 0.0000
847 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
848 PRODUCT PRESCRIBING ERROR 1 0.0000
849 MOBILITY DECREASED 3 0.0000
850 FEELING ABNORMAL 10 0.0000
851 ABDOMINAL DISCOMFORT 7 0.0000
852 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
853 DIABETIC KETOACIDOSIS 1 0.0000
854 DRUG INTOLERANCE 4 0.0000
855 EMOTIONAL DISTRESS 5 0.0000
856 CONSTIPATION 9 0.0000
857 CEREBRAL INFARCTION 1 0.0000
858 LUNG DISORDER 2 0.0000
859 OSTEONECROSIS OF JAW 1 0.0000
860 AGEUSIA 1 0.0000
861 DRY EYE 2 0.0000
862 PNEUMONIA ASPIRATION 1 0.0000
863 HEADACHE 25 0.0000
864 CELLULITIS 2 0.0000
865 ABDOMINAL PAIN LOWER 1 0.0000
866 DRUG INEFFECTIVE 52 0.0000
867 CARDIOVASCULAR DISORDER 1 0.0000
868 INJECTION SITE SWELLING 3 0.0000
869 HYPOPHAGIA 1 0.0000
870 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
871 INFLAMMATION 2 0.0000
872 DEAFNESS 1 0.0000
873 MUCOSAL INFLAMMATION 1 0.0000
874 JOINT STIFFNESS 1 0.0000
875 DEPRESSED MOOD 2 0.0000
876 EAR INFECTION 1 0.0000
877 DRY SKIN 5 0.0000
878 DISTURBANCE IN ATTENTION 2 0.0000
879 DRY MOUTH 3 0.0000
880 LIMB INJURY 1 0.0000
881 PALLOR 1 0.0000
882 PNEUMONITIS 1 0.0000
883 GAIT DISTURBANCE 7 0.0000
884 TREATMENT NONCOMPLIANCE 2 0.0000
885 MEMORY IMPAIRMENT 5 0.0000
886 ABNORMAL DREAMS 1 0.0000
887 CONDITION AGGRAVATED 11 0.0000
888 MEDICATION ERROR 2 0.0000
889 URTICARIA 6 0.0000
890 RENAL IMPAIRMENT 3 0.0000
891 BLISTER 2 0.0000
892 EYE PAIN 2 0.0000
893 PAIN IN JAW 1 0.0000
894 ANGINA PECTORIS 1 0.0000
895 EYE IRRITATION 2 0.0000
896 PANCREATIC CARCINOMA 1 0.0000
897 BONE PAIN 2 0.0000
898 VOMITING 16 0.0000
899 BLADDER CANCER 2 0.0000
900 PRURITUS 13 0.0000
901 WHEEZING 2 0.0000
902 OESOPHAGEAL CARCINOMA 1 0.0000
903 GASTROINTESTINAL DISORDER 3 0.0000
904 IRRITABILITY 2 0.0000
905 JOINT SWELLING 4 0.0000
906 PLEURAL EFFUSION 2 0.0000
907 VERTIGO 2 0.0000
908 EPILEPSY 1 0.0000
909 ADVERSE EVENT 3 0.0000
910 EMOTIONAL DISORDER 1 0.0000
911 VISUAL IMPAIRMENT 4 0.0000
912 CARDIAC DISORDER 3 0.0000
913 PYREXIA 11 0.0000
914 MOVEMENT DISORDER 1 0.0000
915 NIGHT SWEATS 1 0.0000
916 INCORRECT DOSE ADMINISTERED 7 0.0000
917 PRODUCT DOSE OMISSION ISSUE 9 0.0000
918 OSTEONECROSIS 1 0.0000
919 INFUSION RELATED REACTION 2 0.0000
920 FEBRILE NEUTROPENIA 2 0.0000
921 FUNGAL INFECTION 1 0.0000
922 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
923 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
924 ANGER 1 0.0000
925 NIGHTMARE 1 0.0000
926 ABDOMINAL DISTENSION 3 0.0000
927 HAEMORRHAGE 3 0.0000
928 HYPOXIA 1 0.0000
929 SLEEP DISORDER 2 0.0000
930 LYMPHADENOPATHY 1 0.0000
931 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
932 THERAPY INTERRUPTED 2 0.0000
933 NO ADVERSE EVENT 5 0.0000
934 DRUG EFFECT INCOMPLETE 1 0.0000
935 ACCIDENTAL OVERDOSE 1 0.0000
936 DYSARTHRIA 1 0.0000
937 ASTHMA 3 0.0000
938 COLITIS 1 0.0000
939 ACNE 2 0.0000
940 ABNORMAL BEHAVIOUR 1 0.0000
941 INJECTION SITE BRUISING 2 0.0000
942 THROMBOSIS 2 0.0000
943 INJECTION SITE ERYTHEMA 3 0.0000
944 TREATMENT FAILURE 2 0.0000
945 CARDIO-RESPIRATORY ARREST 1 0.0000
946 SKIN EXFOLIATION 2 0.0000
947 HYPOACUSIS 1 0.0000
948 MENTAL DISORDER 1 0.0000
949 PSORIASIS 3 0.0000
950 RASH 10 0.0000
951 ANGIOEDEMA 1 0.0000
952 DEATH 19 0.0000
953 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
954 NEPHROLITHIASIS 1 0.0000
955 BREAST CANCER 2 0.0000
956 OCULAR HYPERAEMIA 1 0.0000
957 PULMONARY EMBOLISM 2 0.0000
958 DISEASE RECURRENCE 1 0.0000
959 COMA 1 0.0000
960 PRODUCTIVE COUGH 1 0.0000
961 INFECTION 3 0.0000
962 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
963 ECZEMA 1 0.0000
964 PANCREATITIS 1 0.0000
965 PLATELET COUNT DECREASED 2 0.0000
966 OVERDOSE 4 0.0000
967 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
968 OFF LABEL USE 16 0.0000
969 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
970 ANAPHYLACTIC REACTION 1 0.0000
971 PANCYTOPENIA 1 0.0000
972 THROMBOCYTOPENIA 2 0.0000
973 COVID-19 3 0.0000
974 HYPERSENSITIVITY 3 0.0000
975 EXPOSURE DURING PREGNANCY 1 0.0000
976 PRODUCT USE ISSUE 3 0.0000
977 INTENTIONAL OVERDOSE 1 0.0000
978 PRODUCT DOSE OMISSION 1 0.0000
979 NEOPLASM MALIGNANT 1 0.0000
980 HEPATIC ENZYME INCREASED 1 0.0000
981 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
982 DEVICE MALFUNCTION 1 0.0000
983 INJECTION SITE PAIN 4 0.0000
984 INJECTION SITE HAEMORRHAGE 1 0.0000
985 PROSTATE CANCER 1 0.0000
986 INTENTIONAL PRODUCT MISUSE 1 0.0000
987 DISEASE PROGRESSION 1 0.0000
988 PRODUCT QUALITY ISSUE 1 0.0000
989 DRUG DEPENDENCE 1 0.0000